ROIV - CIK 0001635088
Roivant Sciences Ltd. (ROIV) reported revenue of $8.26M for fiscal year 2026, as filed in its audited annual report with the SEC.
| Fiscal year | Revenue | Change |
|---|---|---|
| FY 2026 | $8.26M | -71.6% |
| FY 2025 | $29.05M | -11.2% |
| FY 2024 | $32.71M | +3.8% |
| FY 2023 | $31.53M | -43.0% |
| FY 2022 | $55.29M | +132.3% |
| FY 2021 | $23.80M | - |
Roivant Sciences Ltd. (ROIV) reported revenue of $8.26M for fiscal year 2026, as filed in its audited annual report with the SEC.
Between fiscal 2021 and fiscal 2026, Roivant Sciences Ltd.'s revenue declined from $23.80M to $8.26M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.